End-of-day quote
Shenzhen S.E.
23:00:00 23/05/2024 BST
|
5-day change
|
1st Jan Change
|
15.88
CNY
|
-0.44%
|
|
-5.48%
|
-35.34%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
---|
Capitalization
1 |
7,720
|
3,139
|
3,930
|
Enterprise Value (EV)
1 |
7,167
|
2,688
|
3,598
|
P/E ratio
|
101
x
|
93.4
x
|
117
x
|
Yield
|
0.33%
|
0.51%
|
0.41%
|
Capitalization / Revenue
|
22.1
x
|
11.1
x
|
13.4
x
|
EV / Revenue
|
20.5
x
|
9.49
x
|
12.3
x
|
EV / EBITDA
|
96.2
x
|
82.5
x
|
103
x
|
EV / FCF
|
118
x
|
49.5
x
|
-63.8
x
|
FCF Yield
|
0.85%
|
2.02%
|
-1.57%
|
Price to Book
|
10.3
x
|
4.14
x
|
5.06
x
|
Nbr of stocks (in thousands)
|
160,000
|
160,000
|
160,000
|
Reference price
2 |
48.25
|
19.62
|
24.56
|
Announcement Date
|
24/04/22
|
27/04/23
|
22/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
290.5
|
316.6
|
341
|
349.8
|
283.3
|
292.4
|
EBITDA
1 |
81.37
|
82.9
|
75.72
|
74.47
|
32.57
|
34.9
|
EBIT
1 |
73.32
|
74.11
|
64.33
|
60.51
|
21.45
|
24.46
|
Operating Margin
|
25.24%
|
23.41%
|
18.87%
|
17.3%
|
7.57%
|
8.37%
|
Earnings before Tax (EBT)
1 |
74.38
|
80.18
|
72.46
|
66.72
|
34.75
|
37.29
|
Net income
1 |
63.6
|
66.63
|
62.52
|
57.18
|
33.42
|
33.5
|
Net margin
|
21.89%
|
21.05%
|
18.34%
|
16.35%
|
11.79%
|
11.46%
|
EPS
2 |
0.5300
|
0.5600
|
0.5200
|
0.4800
|
0.2100
|
0.2100
|
Free Cash Flow
1 |
31.02
|
11.58
|
8.476
|
60.76
|
54.26
|
-56.42
|
FCF margin
|
10.68%
|
3.66%
|
2.49%
|
17.37%
|
19.15%
|
-19.29%
|
FCF Conversion (EBITDA)
|
38.12%
|
13.97%
|
11.19%
|
81.59%
|
166.61%
|
-
|
FCF Conversion (Net income)
|
48.77%
|
17.39%
|
13.56%
|
106.26%
|
162.38%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
0.1600
|
0.1000
|
0.1000
|
Announcement Date
|
29/12/20
|
29/12/20
|
24/04/22
|
24/04/22
|
27/04/23
|
22/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
94
|
102
|
134
|
553
|
451
|
331
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
31
|
11.6
|
8.48
|
60.8
|
54.3
|
-56.4
|
ROE (net income / shareholders' equity)
|
32.1%
|
26.6%
|
21%
|
10.6%
|
4.43%
|
4.23%
|
ROA (Net income/ Total Assets)
|
15.8%
|
14.9%
|
11.3%
|
6.25%
|
1.59%
|
1.79%
|
Assets
1 |
401.4
|
448
|
551.3
|
914.8
|
2,098
|
1,877
|
Book Value Per Share
2 |
1.920
|
2.260
|
2.700
|
4.690
|
4.740
|
4.850
|
Cash Flow per Share
2 |
0.7800
|
0.6200
|
0.9000
|
3.030
|
1.120
|
0.8200
|
Capex
1 |
1.35
|
12.8
|
46.1
|
3.09
|
5.54
|
38.6
|
Capex / Sales
|
0.47%
|
4.05%
|
13.52%
|
0.88%
|
1.96%
|
13.21%
|
Announcement Date
|
29/12/20
|
29/12/20
|
24/04/22
|
24/04/22
|
27/04/23
|
22/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -35.34% | 351M | | +38.51% | 727B | | +33.05% | 599B | | -6.23% | 354B | | +18.78% | 328B | | +1.35% | 277B | | +16.00% | 243B | | +8.09% | 205B | | -5.77% | 203B | | +6.19% | 164B |
Other Pharmaceuticals
|